HIGHLIGHTS
- who: ROS et al. from the Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China, National Center for Neurological have published the article: The Anti-Glioma Effect of Juglone Derivatives through ROS Generation, in the Journal: (JOURNAL)
- future: Hepatotoxicity remains which needs to be improved in a future experiments.
SUMMARY
Despite the advance in molecular research of GBM, the overall survival remains as poor as 14.6 months even after comprehensive management (Stupp et_al, 2005; Zhu et_al, 2017). Mass spectra were obtained on a Thermo Finnigan MAT 95 XL spectrometer, Shanghai . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.